Maverick Biomaterials Progressing towards 13485 Certification.

Maverick Biomaterials is making solid progress towards probable attainment of ISO 13485 certification for Q1 2012.

A Notify body audit will be completed late in the year with Mavericks Quality Manager quietly confident of a successful outcome. This will be well received by clients soon to progress beyond animal trials for device’ utilising Mavericks custom sourced and produced materials. Some clients choose and approve Mavericks custom sourced produced materials for their manufacturing of Percutaneous Valves, among other devices.

PRESS RELEASES

Glutaraldehyde processing work commences in Dubbo, Australia

Jun 10, 2009

Maverick has been working with a number of start-up clients to resolve their need for "backroom" processing activities to be undertaken as an outsourced function so as to reduce their infrastructural investment and provide them more time and focus on key objectives....

New Zealand production of device tissues commenced on an ongoing basis

May 1, 2009

After completion of a number of validation shipments Maverick New Zealand has commenced ongoing production of device tissues this month against a clients need for a dual sourced supply chain to meet regulatory requirements, and board directives to manage disease risk....

Maverick to produce sized porcine leaflets

Feb 1, 2009

Maverick has this week, drafted a project plan for the production and selection of sized porcine leaflets, for fixation in Australia, prior to export. Expanding upon its success in the bovine and equine tissues area, Maverick has built a project plan for a customised...

PRODUCT CATEGORIES